Germany · Series E startup
2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Ganymed Pharmaceuticals and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$92Mraised across 2 rounds since 2007, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
VI Partners
Landesbank Baden WurttembergFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Declaration PartnersVI PartnersIngro Finanz AG
FCPBLandesbank Baden WurttembergFuture Capital AGMIG FondMissing a round, or an investor who was in one? Tell us.
Ganymed Pharmaceuticals's investors include Declaration Partners, VI Partners, Ingro Finanz AG, FCPB and Landesbank Baden Wurttemberg, and 2 more on record.
Ganymed Pharmaceuticals has raised $92M across 2 rounds since 2007.
Ganymed Pharmaceuticals's most recent round was a Series E of $58M in Nov 2013.
Its most recent round, $58M in Nov 2013, is also its largest on record.
Ganymed Pharmaceuticals's first round on record, in Apr 2007, was backed by VI Partners, Ingro Finanz AG and Landesbank Baden Wurttemberg and 1 others.
Ganymed Pharmaceuticals's latest named round is a Series E, in Nov 2013.
Ganymed Pharmaceuticals is based in Germany.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Germany ·